Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data

Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data

ABSTRACT: Background: Atypical antipsychotics (AAPs) with mood stabilizers are recommended as a first-line treatment for patients with bipolar disorder. No studies have compared the inpatient health care resource utilization for patients with bipolar disorder treated with lurasidone as adjunctive th...

Full description

Bibliographic Details
Main Authors: Xiaoli Niu, PhD, Syvart Dennen, MPhil, Carole Dembek, MS, Kimberly Laubmeier, PhD, Yanmei Liu, MS, Phani Veeranki, MD, DrPH, Michael Tocco, PhD, G. Rhys Williams, ScD
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Current Therapeutic Research
Subjects:
Atypical antipsychotics
Bipolar I disorder
Hospitalization
lurasidone
Medicaid
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X21000072

Internet

http://www.sciencedirect.com/science/article/pii/S0011393X21000072

Similar Items